Human Molecular Genetics, 2001, Vol. 10, No. 18 1945-1952
© 2001 Oxford University Press
Telomere maintenance by telomerase and by recombination can coexist in human cells
Department of Pathology and Molecular Medicine, McMaster University HSC-4H30, 1200 Main Street West, Hamilton, ON L8N 3Z5, Canada and 1Unité INSERM 434, 27 rue Juliette Dodu, Paris 75010, France
Immortal human cells maintain their telomeres by two independent mechanisms, a prevalent one dependent on de novo synthesis of telomeric DNA by telomerase, and a rarer one based on telomere recombination [alternative lengthening of telomeres (ALT)]. Studies with yeast have indicated that expression of telomerase inhibits telomere recombination. In the present study, we have investigated whether expression of telomerase in cells that use ALT would similarly reveal dominance of telomere elongation by telomerase over telomere recombination. Telomerase-negative WI38 VA13/2RA ALT cells were reconstituted for telomerase activity through ectopic expression of the enzyme subunits, hTERT and hTR, and the presence and function of telomerase and ALT were monitored during long term cell growth by enzymatic assays, detection of the ALT-associated PML bodies (APBs) and analysis of telomere dynamics. Our results indicate that telomerase activity and APBs persisted in the cells over at least 90 population doublings. The activity of both pathways on telomeres was determined by analysis of telomere length versus time by gel electrophoresis and in situ hybridization. ALT cells are characterized by very heterogeneous telomeres with a much longer average size than the telomeres of telomerase-positive cells. Telomere dynamics in our cells were compatible with both ALT and telomerase being biologically active since the long telomeres typical of ALT were maintained, while short telomeres, thought to be the preferential substrate of telomerase, were elongated. These findings, indicating that human cells may be capable of concomitantly utilizing both mechanisms of telomere maintenance without effects on their growth and viability, have implications for cancer therapy.
+ To whom correspondence should be addressed. Tel: +1 905 525 9140; Fax: +1 905 546 9940; Email: bacchett@mcmaster.ca
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. S. Y. Ting, B. Pohorelic, Y. Yu, S. P. Lees-Miller, and T. L. Beattie The human telomerase RNA component, hTR, activates the DNA-dependent protein kinase to phosphorylate heterogeneous nuclear ribonucleoprotein A1 Nucleic Acids Res., October 1, 2009; 37(18): 6105 - 6115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Draskovic, N. Arnoult, V. Steiner, S. Bacchetti, P. Lomonte, and A. Londono-Vallejo Probing PML body function in ALT cells reveals spatiotemporal requirements for telomere recombination PNAS, September 15, 2009; 106(37): 15726 - 15731. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Shammas, A. Qazi, R. B. Batchu, R. C. Bertheau, J. Y.Y. Wong, M. Y. Rao, M. Prasad, D. Chanda, S. Ponnazhagan, K. C. Anderson, et al. Telomere Maintenance in Laser Capture Microdissection-Purified Barrett's Adenocarcinoma Cells and Effect of Telomerase Inhibition In vivo Clin. Cancer Res., August 1, 2008; 14(15): 4971 - 4980. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Villa, M. G. Daidone, R. Motta, L. Venturini, C. De Marco, A. Vannelli, S. Kusamura, D. Baratti, M. Deraco, A. Costa, et al. Multiple Mechanisms of Telomere Maintenance Exist and Differentially Affect Clinical Outcome in Diffuse Malignant Peritoneal Mesothelioma Clin. Cancer Res., July 1, 2008; 14(13): 4134 - 4140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Multani and S. Chang WRN at telomeres: implications for aging and cancer J. Cell Sci., March 1, 2007; 120(5): 713 - 721. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Costa, M. G. Daidone, L. Daprai, R. Villa, S. Cantu, S. Pilotti, L. Mariani, A. Gronchi, J. D. Henson, R. R. Reddel, et al. Telomere Maintenance Mechanisms in Liposarcomas: Association with Histologic Subtypes and Disease Progression. Cancer Res., September 1, 2006; 66(17): 8918 - 8924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Cerone, J. A. Londono-Vallejo, and C. Autexier Telomerase inhibition enhances the response to anticancer drug treatment in human breast cancer cells. Mol. Cancer Ther., July 1, 2006; 5(7): 1669 - 1675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. R. Laud, A. S. Multani, S. M. Bailey, L. Wu, J. Ma, C. Kingsley, M. Lebel, S. Pathak, R. A. DePinho, and S. Chang Elevated telomere-telomere recombination in WRN-deficient, telomere dysfunctional cells promotes escape from senescence and engagement of the ALT pathway Genes & Dev., November 1, 2005; 19(21): 2560 - 2570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. T. Marie-Egyptienne, M. A. Cerone, J. A. Londono-Vallejo, and C. Autexier A human-Tetrahymena pseudoknot chimeric telomerase RNA reconstitutes a nonprocessive enzyme in vitro that is defective in telomere elongation Nucleic Acids Res., September 28, 2005; 33(17): 5446 - 5457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Ward and C. Autexier Pharmacological Telomerase Inhibition Can Sensitize Drug-Resistant and Drug-Sensitive Cells to Chemotherapeutic Treatment Mol. Pharmacol., September 1, 2005; 68(3): 779 - 786. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-Q. Jiang, Z.-H. Zhong, J. D. Henson, A. A. Neumann, A. C.-M. Chang, and R. R. Reddel Suppression of Alternative Lengthening of Telomeres by Sp100-Mediated Sequestration of the MRE11/RAD50/NBS1 Complex Mol. Cell. Biol., April 1, 2005; 25(7): 2708 - 2721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-i. Kumakura, T. W. Tsutsui, J. Yagisawa, J. C. Barrett, and T. Tsutsui Reversible Conversion of Immortal Human Cells from Telomerase-Positive to Telomerase-Negative Cells Cancer Res., April 1, 2005; 65(7): 2778 - 2786. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Sanders, R. Drissi, C. A. Billups, N. C. Daw, M. B. Valentine, and J. S. Dome Telomerase Expression Predicts Unfavorable Outcome in Osteosarcoma J. Clin. Oncol., September 15, 2004; 22(18): 3790 - 3797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Bailey, M. A. Brenneman, and E. H. Goodwin Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells Nucleic Acids Res., July 16, 2004; 32(12): 3743 - 3751. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. R. A. Razak, R. J. Varkonyi, M. Kulp-McEliece, C. Caslini, J. R. Testa, M. E. Murphy, and D. Broccoli p53 Differentially Inhibits Cell Growth Depending on the Mechanism of Telomere Maintenance Mol. Cell. Biol., July 1, 2004; 24(13): 5967 - 5977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Londono-Vallejo, H. Der-Sarkissian, L. Cazes, S. Bacchetti, and R. R. Reddel Alternative Lengthening of Telomeres Is Characterized by High Rates of Telomeric Exchange Cancer Res., April 1, 2004; 64(7): 2324 - 2327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Dantzer, M.-J. Giraud-Panis, I. Jaco, J.-C. Ame, I. Schultz, M. Blasco, C.-E. Koering, E. Gilson, J. Menissier-de Murcia, G. de Murcia, et al. Functional Interaction between Poly(ADP-Ribose) Polymerase 2 (PARP-2) and TRF2: PARP Activity Negatively Regulates TRF2 Mol. Cell. Biol., February 15, 2004; 24(4): 1595 - 1607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-D. Wu, L. M. Orme, J. Shaughnessy Jr, J. Jacobson, B. Barlogie, and M. A. S. Moore Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival Blood, June 15, 2003; 101(12): 4982 - 4989. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Stavropoulos, P. S. Bradshaw, X. Li, I. Pasic, K. Truong, M. Ikura, M. Ungrin, and M. S. Meyn The Bloom syndrome helicase BLM interacts with TRF2 in ALT cells and promotes telomeric DNA synthesis Hum. Mol. Genet., December 1, 2002; 11(25): 3135 - 3144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chang and R. A. DePinho Telomerase extracurricular activities PNAS, October 1, 2002; 99(20): 12520 - 12522. [Full Text] [PDF]
|
|
|
|
|
|
S. A. Stewart, W. C. Hahn, B. F. O'Connor, E. N. Banner, A. S. Lundberg, P. Modha, H. Mizuno, M. W. Brooks, M. Fleming, D. B. Zimonjic, et al. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism PNAS, October 1, 2002; 99(20): 12606 - 12611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. V. Grobelny, M. Kulp-McEliece, and D. Broccoli Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway Hum. Mol. Genet., September 1, 2001; 10(18): 1953 - 1961. [Abstract] [Full Text] [PDF]
|
|